GRIPAP1 Antikörper (AA 311-371)
Kurzübersicht für GRIPAP1 Antikörper (AA 311-371) (ABIN1886358)
Target
Alle GRIPAP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 311-371
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 311 and 371 of GRASP1
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.100-1.1000
Immunofluorescence: 1.100-1.200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- GRIPAP1 (GRIP1 Associated Protein 1 (GRIPAP1))
-
Andere Bezeichnung
- GRASP1
-
Hintergrund
-
GRASP1 is a neuron-specific guanine nucleotide exchange factor for the Ras family of small G proteins (RasGEF) and is associated with the GRIP/AMPA receptor complex in brain (Ye et al., 2000 [PubMed 10896157]).[supplied by OMIM]
Synonyms: GRASP-1, KIAA1167, MGC126593, MGC126595, DKFZp434P0630 -
Molekulargewicht
- 96 kDa
-
Gen-ID
- 56850
-
NCBI Accession
- NM_020137, NP_064522
-
Pathways
- SARS-CoV-2 Protein Interaktom
Target
-